Ex vivo 3D micro-tumor testing platform for predicting clinical response to platinum-based therapy in patients with high-grade serous ovarian cancer.

Category Primary study
Conference2025 ASCO Annual Meeting
Year 2025
This article has no abstract
Epistemonikos ID: 9cbdece4378d9a65b553e73cf62670cbe3623426
First added on: May 18, 2026